Combined Artificial Intelligence and Mobile Application for Remote Infant Motor Screening: Development and Validation
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Jul 22, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new mobile app called "Baby Go" version 3.0, which aims to help parents monitor their infants' motor skills from home. The app will allow parents to assess their baby's movements using videos and provide guidance on what to expect as their child grows. The trial will also test an artificial intelligence (AI) system that analyzes these videos to see how well it assesses motor development compared to what parents observe. By doing this, the researchers hope to create a useful tool for both parents and healthcare providers.
To be eligible for the study, infants must be either preterm (born before 37 weeks of pregnancy) or term (born between 37 and 42 weeks), and they should be between 2 to 18 months old. Additionally, the clinicians who work with these infants and their families can also participate. However, parents and clinicians must be able to read Chinese to join the study. If you decide to participate, you can expect to use the app at home, submit videos of your baby, and receive feedback on their motor skills, while contributing to important research that could help improve early intervention for motor disorders.
Gender
ALL
Eligibility criteria
- The inclusion criterion is:
- • Preterm infants: gestational age \< 37 weeks, birth body weight \< 2,500 grams, and corrected age of 2-18 months.
- • Term infants: gestational age 37-42 weeks, birth body weight \>2,500 grams, and age of 2-18 months.
- • Clinicians: who provide early intervention to the participating infants in this study.
- The exclusion criterion is:
- • Infants: parents can not read Chinese. Clinicians: can not read Chinese
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, Taiwan, 100, , Taiwan
Patients applied
Trial Officials
Suh-Fang Jeng, Professor
Principal Investigator
School and Graduate Institute of Physical Therapy, National Taiwan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported